Prevalence and Risk of MAFLD and Liver Fibrosis in Patients With IBD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Gastroenterology and Hepatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Increased risk of MAFLD and Liver Fibrosis in Inflammatory Bowel Disease Independent of Classic Metabolic Risk Factors
Clin. Gastroenterol. Hepatol. 2023 Feb 01;21(2)406-414.e7, JC Rodriguez-Duque, JL Calleja, P Iruzubieta, M Hernández-Conde, C Rivas-Rivas, MI Vera, MJ Garcia, M Pascual, B Castro, A García-Blanco, E García-Nieto, SC Olmo, ML Cagigal, L Lopez-Montejo, T Fernández-Lamas, L Rasines, JI Fortea, JP Vaque, Y Frias, M Rivero, MT Arias-Loste, J CrespoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.